J. ;. Mcdonel, B. , C. , and E. , Toxins of Clostridium perfringens types A, Pharmacology of bacterial toxins, pp.477-517, 1986.

M. Bokori-brown, C. G. Savva, F. Da-costa, and S. P. , Molecular basis of toxicity of Clostridium perfringens epsilon toxin, FEBS J, vol.278, pp.4589-4601, 2011.

J. W. Finnie, Pathogenesis of brain damage produced in sheep by Clostridium perfringens type D epsilon toxin: A review, Aust Vet J, vol.81, pp.219-221, 2003.

N. Sakurai and J. , High-affinity binding of Clostridium perfringens epsilon-toxin to rat brain, Infect Immun, vol.60, pp.1237-1240, 1992.

J. Dorca-arevalo, A. Soler-jover, and M. Gibert, Binding of epsilon-toxin from Clostridium perfringens in the nervous system, Vet Microbiol, vol.131, pp.14-25, 2008.

L. Wioland, J. L. Dupont, and F. Doussau, Epsilon toxin from Clostridium perfringens acts on oligodendrocytes without forming pores, and causes demyelination, Cell Microbiol, vol.17, pp.369-388, 2015.

A. Soler-jover, J. Dorca, and M. R. Popoff, Distribution of Clostridium perfringens epsilon toxin in the brains of acutely intoxicated mice and its effect upon glial cells, Toxicon, vol.50, pp.530-540, 2007.

E. Lonchamp, J. L. Dupont, and L. Wioland, Clostridium perfringens epsilon toxin targets granule cells in the mouse cerebellum and stimulates glutamate release, PLoS ONE, vol.5, p.13046, 2010.
URL : https://hal.archives-ouvertes.fr/pasteur-01762143

M. R. Popoff, Epsilon toxin: A fascinating poreforming toxin, FEBS J, vol.278, pp.4602-4615, 2011.
URL : https://hal.archives-ouvertes.fr/pasteur-01791200

M. H. Gleeson-white and J. J. Bullen, Clostridium welchii epsilon toxin in the intestinal contents of man, Lancet, vol.268, pp.384-385, 1955.

J. Kohn and G. H. Warrack, Recovery of Clostridium welchii type D from man, Lancet, vol.268, p.385, 1955.

K. R. Rumah, J. Linden, and V. A. Fischetti, Isolation of Clostridium perfringens type B in an individual

M. Cases, A. Llobet, and B. Terni, Acute effect of pore-forming Clostridium perfringens ?-toxin on compound action potentials of optic nerve of mouse, vol.4, pp.51-68, 2017.

C. H. Polman, S. C. Reingold, and B. Banwell, Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria, Ann Neurol, vol.69, pp.292-302, 2011.

A. R. Cole, M. Gibert, and M. Popoff, Clostridium perfringens epsilon-toxin shows structural similarity to the pore-forming toxin aerolysin, Nat Struct Mol Biol, vol.11, pp.797-798, 2004.

M. Bokori-brown, C. A. Hall, and C. Vance, Clostridium perfringens epsilon toxin mutant Y30A-Y196A as a recombinant vaccine candidate against enterotoxemia, Vaccine, vol.32, pp.2682-2687, 2014.

W. P. Posthumus, J. A. Lenstra, and W. M. Schaaper, Analysis and simulation of a neutralizing epitope of transmissible gastroenteritis virus, J Virol, vol.64, pp.3304-3309, 1990.

K. R. Rumah, Y. Ma, and J. R. Linden, The myelin and lymphocyte protein MAL is required for binding and activity of Clostridium perfringens ?-toxin, PLoS Pathog, vol.11, p.1004896, 2015.

M. Frank, MAL, a proteolipid in glycosphingolipid enriched domains: Functional implications in myelin and beyond, Prog Neurobiol, vol.60, pp.531-544, 2000.

M. S. Weber, B. Hemmer, and S. Cepok, The role of antibodies in multiple sclerosis, Biochim Biophys Acta, vol.1812, pp.239-245, 2011.

D. Miller, F. Barkhof, and X. Montalban, Clinically isolated syndromes suggestive of multiple sclerosis, part I: Natural history, pathogenesis, diagnosis, and prognosis, Lancet Neurol, vol.4, pp.281-288, 2005.

W. J. Brownlee and D. H. Miller, Clinically isolated syndromes and the relationship to multiple sclerosis, J Clin Neurosci, vol.21, pp.2065-2071, 2014.

P. R. Tempest, P. White, and E. D. Williamson, Efficient generation of a reshaped human mAb specific for the alpha toxin of Clostridium perfringens, Protein Eng, vol.7, pp.1501-1507, 1994.

A. Yermakova, D. J. Vance, and N. J. Mantis, Subdomains of ricin's B subunit as targets of toxin neutralizing and non-neutralizing monoclonal antibodies, PLoS ONE, vol.7, p.44317, 2012.

B. A. Cree, C. M. Spencer, and M. Varrin-doyer, Gut microbiome analysis in neuromyelitis optica reveals overabundance of Clostridium perfringens, Ann Neurol, vol.80, pp.443-447, 2016.

K. Berer, L. A. Gerdes, and E. Cekanaviciute, Gut microbiota from multiple sclerosis patients enables spontaneous autoimmune encephalomyelitis in mice, Proc Natl Acad Sci, vol.114, pp.10719-10724, 2017.

E. Cekanaviciute, B. B. Yoo, and T. F. Runia, Gut bacteria from multiple sclerosis patients modulate human T cells and exacerbate symptoms in mouse models, Proc Natl Acad Sci, vol.114, pp.10713-10718, 2017.

S. Jangi, R. Gandhi, and L. M. Cox, Alterations of the human gut microbiome in multiple sclerosis, Nat Commun, vol.7, p.12015, 2016.

H. Tremlett, D. W. Fadrosh, and A. A. Faruqi, Gut microbiota composition and relapse risk in pediatric MS: A pilot study, J Neurol Sci, vol.363, pp.153-157, 2016.